Achyut Healthcare Ltd

Achyut Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 26 June 2026, providing investors with the latest insights into its performance and outlook.

Achyut Healthcare Ltd has surged to a new 52-week high of Rs 9.89 on 24 Jun 2026, marking a remarkable rally that has seen the stock gain 48.46% over the past eight consecutive trading days. This momentum has propelled the micro-cap pharmaceutical player to nearly triple its value from the 52-week low of Rs 3.20, significantly outperforming the Sensex, which has declined 6.85% over the same period.

Achyut Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by touching its all-time high price of Rs.9.89 on 24 June 2026, marking a remarkable phase in its market journey.

Surging past its previous peaks, Achyut Healthcare Ltd touched a fresh 52-week high of Rs 9.36 on 23 Jun 2026, marking a remarkable rally from its low of Rs 3.20 just a year ago. This impressive 181.25% gain has been fuelled by a confluence of strong technical signals and sustained price momentum, setting the stock apart in the Pharmaceuticals & Biotechnology sector.

Achyut Healthcare Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by touching its all-time high price of Rs.9.36 on 23 Jun 2026, marking a remarkable phase in its market journey.

Surging past its previous peaks, Achyut Healthcare Ltd touched a fresh 52-week high of Rs 9.04 on 22 Jun 2026, propelled by a sustained rally that has delivered over 36% returns in just six trading sessions. This milestone caps a remarkable 170.09% gain over the past year, vastly outperforming the Sensex’s decline of 6.30% during the same period.

Achyut Healthcare Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by touching its all-time high price of Rs.9.04 on 22 June 2026, marking a remarkable phase in the company’s market journey.

Achyut Healthcare Ltd has surged to a fresh 52-week high of Rs 8.78 on 19 Jun 2026, marking a remarkable rally of over 154% from its low of Rs 3.20 in the past year. This milestone comes amid a sustained five-day winning streak, reflecting strong price momentum and a confluence of bullish technical indicators that have propelled the stock well above its key moving averages.

Achyut Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 19 Jun 2026 by touching its all-time high price of Rs.8.78. This achievement marks a notable phase in the company’s market journey, reflecting sustained gains and a bullish technical trend over recent months.

Achyut Healthcare Ltd has surged to a new 52-week high of Rs 7.04, marking a remarkable 102.01% gain over the past year, significantly outperforming the Sensex which declined by 5.12% during the same period. This milestone reflects a sustained rally fuelled by strong technical momentum and a confluence of bullish indicators across multiple timeframes.

Extending its winning streak to four consecutive sessions, Achyut Healthcare Ltd surged to a fresh all-time high of Rs 6.99 on 18 Jun 2026, outperforming its sector and the broader Sensex amid strong technical momentum and robust delivery volumes.

Achyut Healthcare Ltd has surged to a new 52-week high of Rs 6.89 on 17 Jun 2026, marking an impressive 83.8% gain over the past year. This milestone comes amid a sustained rally supported by a confluence of bullish technical indicators and a broader market environment that has seen selective strength in mid and small cap indices.

Achyut Healthcare Ltd has reached a significant milestone by touching its all-time high price of Rs 6.83 on 17 Jun 2026, reflecting a remarkable journey of growth and resilience within the Pharmaceuticals & Biotechnology sector.

Achyut Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Achyut Healthcare Ltd has seen its investment rating upgraded from Sell to Hold as of 3 June 2026, reflecting a nuanced shift in its overall profile. The upgrade is driven primarily by an improvement in the company’s quality metrics, while valuation concerns and mixed technical signals temper enthusiasm. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the rating change, providing investors with a comprehensive view of the stock’s current standing.

Achyut Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 29 May 2026, reflecting a notable improvement in its quality metrics despite persistent concerns over its valuation and financial trends. The micro-cap pharmaceutical and biotechnology company’s Mojo Score has risen to 35.0, signalling a cautious but more favourable outlook amid mixed fundamentals and technical signals.